Global Infectious Disease Diagnostics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026
-
4774
-
May 2023
-
156
-
-
This report was compiled by Correspondence Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
MarketResearch.biz delivers in-depth insights on the global infectious disease diagnostics market in its upcoming report titled, “Global Infectious Disease Diagnostics Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global infectious disease diagnostics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global infectious disease diagnostics market report has been segmented on the basis of test type, technique, condition, end user, and region.
Infectious disease, also known as transmissible disease or communicable disease, is illness resulting from an infection. Infectious disease diagnostics is the process of identifying presence of foreign antigen/organisms with the help of various diagnostic tools.
High prevalence coupled with increasing incidence of infectious diseases are major factors driving growth of the global infectious disease diagnostics market. In addition, technological advancements in diagnostic equipment, increasing government initiatives for development of proper healthcare infrastructure in emerging economies, and high awareness about disease diagnostics in developed economies are other major factors anticipated to boost growth of the global infectious disease diagnostics market over the forecast period.
However, increasing healthcare costs in developed economies coupled with lack of awareness about infectious disease diagnosis in emerging economies are major factors restraining growth of the global infectious disease diagnostics market. Additionally, lack of proper reimbursement policies in developed economies and in some developing economies is another major factor expected to hamper growth of the global infectious disease diagnostics market over the forecast period.
A major and rising trend in the infectious disease diagnostics market is increasing adoption of technologically advanced visual diagnostic equipment in healthcare institutions in developing economies. This is another factor anticipated to fuel growth of the global market over the forecast period.
Currently, the market in North America dominates the global infectious disease diagnostics market in revenue terms owing to presence of proper healthcare system coupled with high prevalence rate of infectious diseases in the region. The market in Europe accounted for second-highest revenue share in the global infectious disease diagnostics market, followed by markets in Latin America, Asia Pacific and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increase incidence of infectious diseases and rise in government initiatives for the improvement of healthcare facilities in emerging economies in the region.
Global infectious disease diagnostics market segmentation:
By test type:
- Laboratory tests
- Imaging test
- Biopsies
By technique:
- Conventional techniques
- Gram-stain
- Pathogen culturing
- Biochemical techniques
- ELISA
- Enzyme immunoassay
- Agglutination
- Molecular techniques
- PCR
- Nucleic acid sequence based amplification
By condition:
- Bacterial Infection
- Viral Infection
- CNS infections
- Cardiovascular infection
- Fungal infection
- GI infections
- Sexually transmitted disease
- Others
By end user:
- Diagnostic laboratories
- Academic and medical institutes
- Contract Research Organization
- Hospitals and Surgical centers
- Ambulatory clinics
- Home healthcare
By region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- Becton Dickinson & Company
- Cepheid Inc.
- Abbott Laboratories
- BioMerieux
- Hologic Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Affymetrix, Inc.
- Alere Inc.
- DiaSorin S.p.A.